“Neuregulin-4 (Nrg-4) as a Metabolic Regulator: A Comprehensive Review of Its Association with Dyslipidemia and Liver Function Abnormalities in Newly Diagnosed Type 2 Diabetes Mellitus”, VER, vol. 8, no. 19s, pp. 177–181, Dec. 2025, doi: 10.64149/J.Ver.8.19s.177-181.